Martin W. Bergmann presents the 3-month results of the PRELIEVE Trial, a pilot study to assess the safety and efficacy of a novel atrial flow regulator that aims to reduce elevated left atrial pressure in patients with heart failure. Can the device improve symptoms of dyspnoea...

Nicolas Dumonteil (France) and Maurizio Taramasso (Switzerland) talk about the relatively recent development of tricuspid interventions. Clinical and anatomical selection criteria for these high-risk patients are considered, and a comprehensive overview of multimodal imaging and devices is provided. The therapeutic options for reducing TR and improving...

Read interviews with two previous winners of EuroPCR’s unique abstract competition: Dejan Milasinovic and Yousif Ahmad

Transcatheter mitral valve replacement (TMVR) may improve the outcomes for patients with mitral regurgitation. Vinay Badhwar describes the results of an initial feasibility study for the first 100 patients with symptomatic mitral regurgitation at high or prohibitive surgical risk to be treated with TMVR using the...

Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...

Lynne Hinterbuchner (Germany) talks with Gerda Donnelly (Germany) about educating nurses and allied professions about newly introduced technology for the treatment of mitral insufficiency. They discuss the best preparation for nurses, the importance of the Heart Team as a whole to become familiar with the new...

PCROnline Editor Davide Capodanno raises the hot topic of how to manage antithrombotic therapy in patients with atrial fibrillation who need dual antiplatelet therapy.  He asks Dominick Angiolillo from the USA for practical advice about which anticoagulants and P2Y12 inhibitors to use, and the most difficult...

Michael HAUDE discusses left main trifurcation PCI with Alaide CHIEFFO from Italy, and Darius DUDEK from Poland. They bring their experience of treating this challenging lesion subset to talk about the broad spectrum of techniques required in the interventionalist’s toolbox, the available technologies and the use...

Paris, France, 21 May 2019. This PCR statement on paclitaxel drug-coated balloons (DCB) use in peripheral interventions addresses the controversy raised by the meta-analysis of K. Katsanos, MD, PhD (Patras University Hospital, Rion, Greece) and colleagues, published in late 2018 (https://doi.org/10.1161/JAHA.118.011245). The Katsanos meta-analysis prompted widespread...

Although huge progress has been made over the last four decades in percutaneous coronary intervention, the results in diabetic patients are still suboptimal, with higher rates of restenosis, target lesion revascularisation, vessel failures and mortality. Luca Testa, Roxana Mehran and Ashok Seth discuss the problems that...

Tricuspid regurgitation is notoriously hard to manage, with limited medical treatment options. What are the therapeutic options available and how can the risks to patients of treatment be reduced? Patrizio Lancellotti (Belgium) talks to Stephan Baldus (Germany) and Claudius Jacobshagen (Germany) about the Cardioband tricuspid valve...

Mitral valve repair is a fast moving field in interventional cardiology. Join Jörg Hausleiter and Ralph Stephan von Bardeleben as they talk to Volker Rudolph about the PASCAL transcatheter valve repair system, which has recently been granted a CE mark. Find out the key features that...

More effective, safer treatment is needed for functional mitral regurgitation (FMR), a consequence of myocardial disease and left ventricular disease, which is associated with poor quality of life and high mortality rates. Join Ralph Stephan von Bardeleben, Patrice Guerin and Saibal Kar as they examine the...

Do newer generation drug-eluting stents with ultrathin struts improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI)? Join Ashwin Mehta, Upendra Kaul and Anirban Choudhary in a discussion about the TALENT non-inferiority trial, which compared PCI using the Supraflex sirolimus-eluting stent with ultrathin struts with...

What is the best size of MitraClip to use for functional mitral regurgitation, degenerative mitral regurgitation or commissural lesions? Francesco Maisano (Switzerland), Paolo Denti (Italy) and Ralph Stephan von Bardeleben (Germany) examine the latest data from the EXPAND trial, which show the real-world use of percutaneous...

Are left main bifurcations different from other bifurcations? And is one stent better than two? Find out as Goran Stankovic, David Hildick-Smith and Francesco Burzotta discuss the recommendations of the latest consensus document from the European Bifurcation Club (EBC) dedicated to left main percutaneous coronary intervention...

In this short video Guiseppe Tarantini (Italy) summarises some of the challenges associated with repeat coronary angiography and percutaneous coronary intervention (PCI) after transcatheter aortic valve implantation (TAVI). What is the prevalence of coronary artery disease in patients who have undergone TAVI? What proportion of patients...

Systematic imaging has shown silent injury to the brain in the vast majority of TAVI patients. Jean-Philippe Collet (France) asks Alexandra Lansky (USA and UK) about the incidence, risk factors and protection in periprocedural stroke. From explaining the mechanical causes and the rates of clinical and...

With the results from 3 recent randomised trials and with 2 technologies, Michel Azizi (France) asks Felix Mahfoud (Germany) about the return of renal denervation not only as a treatment of resistant hypertension but also its use in non-end-stage disease and its application in other fields....